Pharmasset, Inc. (NASDAQ:VRUS.DL)
CAPS Rating:
A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.
A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Ridiculous run-up. Typical pharma wannabe IPO. It probably will outperform initially as investors raise the price artificially high, and then tank as it becomes clear that the company will not be profitable for years to come if ever. It would be a good investment if you want to time the market. Get out now! Before it goes plop plop fizz fizz. Whoops, thats another drug company. As for me, I am a geneticist -biochemist who has worked for pharma start-ups, and I think it is safer to invest in the lottery.